Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 26, 2021
G protein-coupled receptor kinase-2 confers isoform-specific calcium sensitivity to dopamine D2 receptor desensitizationRichard Ågren, Kristoffer Sahlholm
Frontiers in Pharmacology|October 29, 2020
Voltage-Dependent Dopamine Potency at D1-Like Dopamine ReceptorsRichard Ågren, Kristoffer Sahlholm
Biomedicines|January 21, 2022
Evidence for Two Modes of Binding of the Negative Allosteric Modulator SB269,652 to the Dopamine D2 ReceptorRichard Ågren, Kristoffer Sahlholm
The International Journal of Neuropsychopharmacology|July 10, 2018
The Beta-Arrestin-Biased Dopamine D2 Receptor Ligand, UNC9994, Is a Partial Agonist at G-Protein-Mediated Potassium Channel ActivationRichard Ågren, Peter Århem, Johanna Nilsson, et al.
Biochemical and Biophysical Research Communications|January 7, 2018
Point mutation of a conserved aspartate, D69, in the muscarinic M2 receptor does not modify voltage-sensitive agonist potencyRichard Ågren, Kristoffer Sahlholm, Johanna Nilsson, et al.
International Journal of Molecular Sciences|April 30, 2021
Dopamine D2 Receptor Agonist Binding Kinetics-Role of a Conserved Serine ResidueRichard Ågren, Tomasz Maciej Stepniewski, Hugo Zeberg, et al.
Molecular Biology and Evolution|June 14, 2023
Major Genetic Risk Factors for Dupuytren's Disease Are Inherited From NeandertalsRichard Ågren, Snehal Patil, Xiang Zhou, et al.
The International Journal of Neuropsychopharmacology|August 7, 2023
In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate AntipsychoticsRichard Ågren, Nibal Betari, Marcus Saarinen, et al.
International Journal of Molecular Sciences|July 14, 2023
An E280K Missense Variant in KCND3/Kv4.3-Case Report and Functional CharacterizationRichard Ågren, Niels Geerdink, Han G Brunner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2022
TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT1A receptor agonist SEP-383856Marcus Saarinen, Ioannis Mantas, Ivana Flais, et al.
Pageof 8